№ lp_1_2_40573
File format: docx
Character count: 5104
File size: 19 KB
This protocol outlines the process for RNA extraction from clinical samples, including FTA cards, for use in RT-PCR reactions, specifically designed for viral RNA purification from plasma, serum, and other clinical samples.
Year:
2015
Region / city:
Global
Topic:
RNA extraction, clinical samples, FTA cards
Document Type:
Protocol
Organization:
CDC, GMRLN, WHO
Author:
CDC
Target Audience:
Laboratory professionals
Period of validity:
N/A
Approval Date:
01/27/2015
Date of Changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Subject:
Drug and Alcohol Testing Procedures
Document Type:
Standard Operating Procedures
Organization:
Transit System
Target Audience:
Drug and Alcohol Program Managers, Transit System Supervisors
Year:
2016
Region / City:
United States
Subject:
Federal Transit Administration Procurement and Contract Clauses
Document Type:
Guidance
Organization / Institution:
Federal Transit Administration (FTA)
Author:
Federal Transit Administration
Target Audience:
FTA recipients, subrecipients, contractors
Period of Validity:
Ongoing
Approval Date:
October 1, 2015
Date of Changes:
March 2013
Year:
2018
Region / City:
Minnesota
Theme:
Intelligent Transportation Systems (ITS)
Document Type:
Systems Engineering Checklist
Organization:
Minnesota Department of Transportation (MnDOT)
Author:
Rashmi Brewer
Target Audience:
Transportation project managers, ITS system engineers
Period of Effectiveness:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / City:
Seattle
Subject:
Equitable Transit Oriented Development, Remnant Parcels, Technical Consultant
Document Type:
Request for Proposals (RFP)
Author:
City of Seattle, Office of Planning & Community Development (OPCD)
Target Audience:
Consultants, Government Agencies, Transit Development Stakeholders
Period of Validity:
February 24, 2024 - May 16, 2024
Date of Approval:
February 24, 2024
Date of Changes:
None specified
Year:
2021
Region / City:
Missouri
Topic:
Public transportation, mobility for seniors and individuals with disabilities
Document Type:
Program Guidelines
Authorizing Agency:
Missouri Department of Transportation (MoDOT)
Target Audience:
Local government agencies, transportation service providers
Period of Validity:
Indefinite
Approval Date:
January 2021
Regulatory Requirements:
ADA, Title VI of the Civil Rights Act of 1964
Funding Source:
Federal Transit Administration (FTA)
Agreement:
Guatemala–Israel Free Trade Agreement (FTA)
Document Type:
Certificate of Origin form with completion instructions
Countries Concerned:
Guatemala; Israel
Purpose:
Certification of originating status of goods for preferential trade
Issuing Authority:
Competent authority of the exporting country
Parties Involved:
Exporter; Producer; Importer; Issuing Authority
Required Information:
Exporter details; Importer details; Country of origin; HS Code; Description of goods; Gross weight or quantity; Commercial invoice number
Certification Method:
Signature and stamp, electronic or manual
Applicable Format:
Electronic and paper certificates
Subject Matter:
Rules of origin and customs identification requirements
Year:
2012
Region / City:
United States
Topic:
Federal Financial Report and Reporting Requirements
Document Type:
Circular
Organization:
Federal Transit Administration
Author:
Federal Transit Administration
Target Audience:
Federal Transit Administrators, Transit Agencies
Period of Effect:
From August 27, 2012 onwards
Approval Date:
August 27, 2012
Date of Changes:
August 27, 2012
Year:
2021
Region / City:
United Kingdom, Australia
Theme:
Digital Trade, Free Trade Agreement
Document Type:
Policy Report
Organization:
Blavatnik School of Government, University of Oxford
Authors:
Emily Jones, Danilo Garrido Alves, Beatriz Kira, Rutendo Tavengerwei
Target Audience:
Researchers, policymakers, digital trade professionals
Effective Period:
2021-2022
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2026
Region / city:
Darmstadt, Germany
Topic:
RNA Aptamers, SELEX, Homooriodictyol
Document type:
Research article
Organization / institution:
TU Darmstadt
Author:
Janis Hoetzel, Cristina Bofill-Bosch, Andres W. Martinez, Martin M. Rudolph, Florian Groher, Beatrix Suess
Target audience:
Researchers, biochemists, molecular biologists
Date of approval:
2026
Date of changes:
2026
Note:
Contextual description
Year:
2021
Region / City:
Not specified
Topic:
RNA Extraction
Document Type:
Standard Operating Procedure (SOP)
Organization:
Not specified
Author:
Subash Kumar Rai
Target Audience:
Laboratory Personnel
Effective Date:
28 Oct 2021
Date of Approval:
28 Oct 2021
Date of Last Review:
Not specified
Period of Validity:
Indefinite
Date of Revision:
Not specified
Year:
2016
Region / city:
Sydney
Subject:
DNA/RNA extraction, laboratory safety
Document type:
Standard Operating Procedure
Organization:
The University of Sydney
Author:
Coleman, N.; Nikolic, A.
Target audience:
Laboratory personnel, researchers
Period of validity:
Ongoing
Approval date:
Not specified
Modification date:
Not specified
Note:
Year
Topic:
Gene Editing
Document Type:
Cheat Sheet
Target Audience:
Educators, Researchers in Genetics
Year:
2023
Region / City:
Not specified
Topic:
DNA and RNA isolation protocols
Document Type:
Supplementary Data
Author:
Not specified
Target Audience:
Researchers in molecular biology and genomics
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2007-2008
Region / City:
Yucatan Peninsula, Mexico
Topic:
Virus discovery, Mosquitoes, Metagenomics
Document type:
Research Article
Organization / Institution:
Iowa State University, University of Cambridge, Universidad Autónoma de Yucatán
Author:
Jermilia Charles, Chandra S. Tangudu, Stefanie L. Hurt, Charlotte Tumescheit, Andrew E. Firth, Julian E. Garcia-Rejon, Carlos Machain-Williams, Bradley J. Blitvich
Target Audience:
Researchers, Academics, Microbiologists
Period of Validity:
Not applicable
Approval Date:
Not mentioned
Date of Changes:
Not applicable
Year:
2020
Region / City:
New South Wales, Australia
Topic:
Biology, SARS-CoV-2, RNA, Vaccination, Infectious Diseases
Document Type:
Educational Resource
Organization / Institution:
New South Wales Education Standards Authority (NESA)
Author:
Not specified
Target Audience:
Year 12 students
Period of Validity:
2020 and onwards
Approval Date:
2017
Date of Changes:
Not specified
Year:
2023
Region / City:
Ohio, USA
Topic:
Nanotechnology, RNA Nanoparticles, Cancer Targeting
Document Type:
Research Article
Organization / Institution:
The Ohio State University, Wexner Medical Center
Author:
Hongzhi Wang, Chiran Ghimire, Hui Li, Mario Vieweger, Congcong Xu, Peixuan Guo
Target Audience:
Researchers, Scientists, Medical Professionals
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Context
Year:
2010
Region / City:
N/A
Subject:
Biomedical Research, Cell Biology, Molecular Biology
Document Type:
Research Methods Supplement
Author:
N/A
Target Audience:
Researchers, Scientists in Biomedical Fields
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year of completion:
2023
Field:
Cancer research and tumor immunology
Research focus:
PPP2R2A deletion and expression in NSCLC and immunotherapy response
Type of document:
Supplementary materials and methods section of a scientific study
Data sources:
cBioPortal Pan-Lung cancer dataset; TCGA pan-cancer RNA-Seq data via Xena Browser; Kmplot survival database
Cell lines:
A549 cells; CMT167 PPP2R2A heterozygous knockout cells
Animal models:
CD11b-DTR mice (Jackson Laboratory, strain 006000); C57BL6 mice
Experimental techniques:
RNA sequencing; Gene Set Enrichment Analysis (GSEA); glycosylation assays with PNGase F and Endo H; adoptive Treg transfer; flow cytometry; Treg suppression assay with CellTrace Violet; ELISA
Repositories:
NCBI GEO (accession number GSE311238)
Analytes:
PD-L1, TNF-α, IFN-γ, IFN-α, IFN-β
Antibodies and reagents:
Anti-Mouse PD-L1 In Vivo Antibody (Clone 10F.9G2, Ichorbio); reagents from BioLegend, STEMCELL Technologies, eBioscience, R&D Systems, PBL Assay Science
Cited works:
Gyorffy B., 2024, Innovation (Camb); Qiu Z. et al., 2020, Cancer Research; Zhou L. et al., 2024, Journal of Clinical Investigation